Acupuncture for Persistent Allergic Rhinitis: a multicentre randomised sham acupuncture controlled trial

Korea Institute of Oriental Medicine (South Korea)0 个研究点目标入组 233 人开始时间: 2009年2月27日最近更新: 2015年1月13日

试验速览

暂无简介。

•1. Diagnosis of PER, with moderate-severe or severe degree, according to the criteria of Allergic Rhinitis and its Impact on Asthma (ARIA) initiative
•2. Completed baseline AR diary and provided written informed consent
•3. Aged greater than or equal to 18 years of age, either sex
•4. Recruited from each centre by the use of local newspaper advertisements and posted notices at each site
•5. Have had PER for greater than 4 days/week, and greater than 4 consecutive weeks

•1. Suffering serious medical conditions such as uncontrolled hypertension, diabetes mellitus requiring insulin injection, past or current malignant tumour, severe dyslipidaemia or liver and kidney dysfunction, anaemia, active pulmonary tuberculosis, other infectious disease or systemic diseases insufficient for acupuncture treatment
•2. Congenital nasal abnormalities
•3. Sinusitis or active asthma
•4. Operation history
•5. Received systemically administered corticosteroids within 6 months before enrolment
•6. Received alternative and complementary modality, i.e. acupuncture or herbal medication for treating AR within 6 months
•Topical oral and nasal H1 blockers, or corticosteroid, or nasal anti-cholinergic medication will be stopped before 1 week before enrolment.

发起方

Korea Institute of Oriental Medicine (South Korea)